Liangxian Cao

This inventor holds 21 USPTO granted patents and 12 published patent applications, plus 6 CIPO patents and 11 EPO patents. Top assignee: Ptc Therapeutics, Inc.. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liangxian Cao. Retrieved from https://idiyas.com/inventor/liangxian-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 12)

% Patents Active = 33.3

CIPO Patents = 6 (Patent Applications = 11)

EPO Patents = 11 (Patent Applications = 20)

Average Co-Inventor Count = 4.4

ph-index = 8

Forward Citations = 164(Granted Patents)

Location History:

Parlin, NJ (US) (2009 - 2016)
East Brunswick, NJ (US) (2019 - 2024)

Company Filing History:

21 out of 186

Ptc Therapeutics, Inc.

patents

Years Active: 2009-2024

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12023335 - Method for treating pancreatic cancer (2024-07-02),

2. 11458126 - DHODH inhibitor for use in treating hematologic cancers (2022-10-04),

3. 11180483 - Substituted reverse pyrimidine Bmi-1 inhibitors (2021-11-23),

4. 10428050 - Substituted reverse pyrimidine Bmi-1 inhibitors (2019-10-01),

5. 9493845 - Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same (2016-11-15),

6. 9476870 - Methods and agents for screening for compounds capable of modulating gene expression (2016-10-25),

7. 9351964 - Methods for treating cancer and non-neoplastic conditions (2016-05-31),

8. 9068234 - Methods and agents for screening for compounds capable of modulating gene expression (2015-06-30),

9. 8940896 - Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis (2015-01-27),

10. 8703726 - Methods for treating prostate conditions (2014-04-22),

11. 8697662 - Methods for treating Kaposi sarcoma (2014-04-15),

12. 8680113 - BMI-1 protein expression modulators (2014-03-25),

13. 8614063 - Methods for screening for compounds for treating cancer (2013-12-24),

14. 8460864 - Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same (2013-06-11),

15. 8426194 - Methods and agents for screening for compounds capable of modulating VEGF expression (2013-04-23),

Title: The Innovative Journey of Inventor Liangxian Cao

Introduction: Liangxian Cao, a talented inventor based in Parlin, NJ (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Liangxian Cao holds several patents in the areas of artificial intelligence, renewable energy, and advanced materials. His most recent patent focuses on a revolutionary method for enhancing solar cell efficiency using nanotechnology.

Career Highlights: With a background in engineering and a passion for innovation, Liangxian Cao has had a remarkable career marked by numerous achievements. He has worked for leading tech companies, where he spearheaded research projects that have led to the development of cutting-edge technologies.

Collaborations: Throughout his career, Liangxian Cao has collaborated with top researchers, scientists, and engineers from around the world. His collaborative efforts have resulted in the successful implementation of innovative solutions to complex technological challenges.

Conclusion: Liangxian Cao's dedication to pushing the boundaries of technology and his relentless pursuit of innovation have established him as a prominent figure in the world of inventors. His work continues to inspire future generations of inventors and researchers to think outside the box and create solutions that shape the future of technology.

Profile summary based on public USPTO records.